Last reviewed · How we verify
NCT05144152: M3-AA
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
trial testing M3 in Colorectal Adenoma in 600 participants. Currently enrolling.
15 December 2024
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 13 December 2021 |
| Primary completion | 15 December 2024 |
| Estimated completion | 15 June 2025 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- M3
- FIT
Conditions studied
- Colorectal Adenoma — all drugs for Colorectal Adenoma →
- Advanced Adenoma — all drugs for Advanced Adenoma →
- Colorectal Polyp — all drugs for Colorectal Polyp →
Sponsor
Chinese University of Hong Kong
Who can join
18 and older, any sex, with Colorectal Adenoma or Advanced Adenoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05144152
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Adenoma
Currently open trials in the same condition.
- NCT07095517 — Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors · Phase 1 · recruiting
- NCT06979232 — Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma Detection: A Randomized · NA · recruiting
- NCT07035691 — New bioMarkers tO straTIfy cOlorectal caNcer Referrals · recruiting
- NCT06715384 — Evaluation of a CAM System for Colorectal Polyp Size Measurement · NA · recruiting
- NCT06612281 — Evaluation of Gixam's Performance in a FIT Negative Population · Phase 2 · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05144152 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 27 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05144152.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing